On feeding and nutrition in Fungiacava eilatensis (Bivalvia, Mytilidae), a commensal living in fungiid corals

The enlarged inhalant siphon of Fungiacava eilatensis opens into the coelenteron of species of fungiid corals with which it lives in commensal association. Material consisting of mucus, zooxanthellae, nematocysts, plankton and inorganic matter, is taken exclusively from the coelenteron. The very mobile foot possibly assists in food collection and in the removal of pseudofaeces; but, with large ctenidia, the bivalve is a typical ciliary feeder. Experiments with labelled zooxanthellae reveal that these are taken into the gut of Fungiacava with subsequent metabolic incorporation of products derived from them. The other prime source of food must be phytoplankton carried in with the feeding currents of the coral, itself carnivorous so that there is no competition for food between commensal and host. The Fungia zooxanthella– Fungiacava association operates as a "Troika" the productivity of which is autoregulated in proportion to the number of bivalves present. The inorganic wastes of the bivalve (as well as those of the coral) are utilized by the zooxanthellae, resultant increase in the algal component becoming available as food to the bivalve. Losses in the cycle are balanced by intake of exogenous food.     

Coccus-shaped Bacillus subtilis cells are inhibited at stage 0 of sporulation

RodA and rodB mutations cause rod-shaped Bacillus subtilis cells to become coccus-shaped when the growth temperature is increased from 30 to 45 degrees C. At 30 degrees C four rod strains sporulated as well as the genetically closely related rod+ strains. In contrast, at 45 degrees C the sporulation frequencies of rod strains decreased approximately 10(2)- to 10(4)-fold, while those of rod+ strains remained either unchanged or decreased only slightly. Temperature shift experiments and ultrastructural data indicated that coccus-shaped cells were unable to form prespore septa and were, therefore, inhibited at stage 0 of sporulation.     

Naloxone reversal of ischemic arrhythmia is stereospecific and suggests role of endogenous opioid peptides in ischemic heart disease.

The effects of the stereoisomers of naloxone during myocardial ischemia were studied. (-)-Naloxone (but not the (+)-isomer naloxone) attenuated the ischemia-induced cardiac arrhythmias, hypotension, and bradycardia that result from coronary artery occlusion in anesthetized rats. From these findings, it may be inferred that endogenous opioid peptides may play a role in the pathophysiology of myocardial ischemia. It is also suggested that naloxone may have therapeutic value in the prevention and treatment of ischemic heart disease.